In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

"Report Uncovers Key Trends, Disease Insights and Clinical Trials Shaping the Future of the Global mRNA Therapeutics Market"Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from ...

RNA-based COVID vaccines may enhance the immune response to certain cancer treatments. Advanced lung and skin cancer patients ...

The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care.

Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology. He's seen here at a Sept. 4, 2025, hearing before the Senate Finance ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Curevac N.V. (($CVAC)) announced an update on their ongoing clinical study. Study Overview: CureVac N.V. is conducting a Phase I study titled ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m in the 2025's year to date (YTD), according to GlobalData’s Pharma ...